financetom
Business
financetom
/
Business
/
ICICI Lombard sees competition in corporate health intensifying
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ICICI Lombard sees competition in corporate health intensifying
Oct 19, 2023 7:34 AM

Gopal Balachandran, CFO of ICICI Lombard General Insurance intends to maintain a growth rate that surpasses industry levels by 100-200 basis points (bps).

For the last 23 years, the general insurance industry in India has grown at 15-16% annually, he noted in an interview with CNBC-TV18.

Balachandran pointed to motor, health, and commercial insurance as the company's focus areas. While the company continues to outperform in the corporate health segment, the competition is firming up, he said.

ICICI Lombard's net profit for Q2 of FY24 declined to ₹577.3 crore from ₹590.5 crore in the corresponding quarter of the previous year, the company remains committed to its strategic objectives.

Balachandran discussed the company's efforts to bring down the combined ratio, which had been in the range of 102-104%. "Our objective is to reduce it to 102% by the end of FY25, and we are on course to achieve that goal," he confirmed.

Regarding the split between the loss ratio and the expense ratio, Balachandran explained that it would depend on the mix of businesses written. However, he noted that from a loss ratio perspective, ICICI Lombard has typically maintained a range of around 70-75%.

Out of the three brokerages assessing ICICI Lombard General Insurance Company, two issued a 'buy' recommendation, anticipating a stock price increase of up to 20% over the next 12 months. This positive outlook follows the insurer's premium growth in the second quarter.

HSBC gave a 'buy' rating with a target price of ₹1,578 per share, translating to a potential gain of 17%, primarily due to the robust growth in premiums.

CLSA also has a 'buy' on ICICI Lombard with a target price of ₹1,640 per share, a potential increase of 20%.

In contrast, analysts at Macquarie have a more cautious stance, with an 'underperform' rating on the stock and a target price of ₹995, which is 26% below the current price.

ICICI Lombard shares were trading 1.48% up at ₹1,378.40 on BSE. The share price had remained flat over the last month.

For more details, watch the accompanying video

(Edited by : Shweta Mungre)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Titan Pharmaceuticals Stock Surges 23% After Hours on Stockholder Approval of Three-Way Merger
Titan Pharmaceuticals Stock Surges 23% After Hours on Stockholder Approval of Three-Way Merger
Aug 26, 2025
Titan Pharmaceuticals, Inc. ( TTNP ) closed regular trading at $5.00 per share on Tuesday, before surging 23% to $6.15 in after-hours trading following stockholder approval of a major business combination. Check out the current price of TTNP stock here.  Stockholders Approve Three-Way Merger Stockholders of the biopharmaceutical company voted overwhelmingly to approve Titan’s proposed business combination with Black Titan...
Japan's Mitsubishi Motors cuts full-year operating profit forecast by 30%
Japan's Mitsubishi Motors cuts full-year operating profit forecast by 30%
Aug 26, 2025
TOKYO (Reuters) -Japanese automaker Mitsubishi Motors cut on Wednesday its forecast for the current fiscal year's operating profit by 30% due to the negative impact from U.S. tariffs, lower expected sales volume and higher selling expenses. The company said it expected to book an operating profit of 70 billion yen ($475.12 million) for the fiscal year through next March, 30...
JD Sports underlying sales fall in second quarter on weak UK
JD Sports underlying sales fall in second quarter on weak UK
Aug 26, 2025
LONDON, Aug 27 (Reuters) - JD Sports Fashion reported a deeper decline in underlying sales for its second quarter, reflecting weakness in the UK, though there were signs of stabilisation in its key U.S. market after a sharp decline in the previous quarter. The group, which makes nearly 40% of its revenue in the United States through its JD Sports,...
COLUMN-Trump tariffs force much-needed petrochemicals contraction: Bousso
COLUMN-Trump tariffs force much-needed petrochemicals contraction: Bousso
Aug 26, 2025
(The opinions expressed here are those of the author, a columnist for Reuters.) * Petrochemicals supply to exceed demand by 20-25% by 2030 * South Korea to cut capacity in reponse to US tariffs * China considers closing loss-making plants By Ron Bousso LONDON, Aug 27 (Reuters) - U.S. President Donald Trump's trade wars are nudging the global plastics industry...
Copyright 2023-2026 - www.financetom.com All Rights Reserved